A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : AB / ameloblastoma

[Related PubMed/MEDLINE]
Total Number of Papers: 36
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   AB  (>> Co-occurring Abbreviation)
Long Form:   ameloblastoma
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2018 Expression of WNT1 in ameloblastoma and its significance. KCOT, NOM, RT-qPCR
2018 Upregulation of Periostin expression in the pathogenesis of ameloblastoma. ---
2017 Correlation between ploidy status using flow cytometry and nucleolar organizer regions in benign and malignant epithelial odontogenic tumors. ABC, AgNORs, CCOC, FCM, FFPE, KCOT, SPF
2017 Focal Adhesion Kinase Expression in Ameloblastoma: A Preliminary Observational Study. DF, FAK
2016 Ameloblastoma vs basal cell carcinoma: an immunohistochemical comparison. BCC
2016 Comparison of immunohistochemical expression of CD10 in keratocystic odontogenic tumor and ameloblastoma. KCOT, OKC
2016 Immunohistochemical expression of K6, K8, K16, K17, K19, maspin, syndecan-1 (CD138), alpha-SMA, and Ki-67 in ameloblastoma and ameloblastic carcinoma: diagnostic and prognostic correlations. AC, alpha-SMA, IHCE, NRABs, RABs
2015 Expression of phosphorylated Akt/mTOR and clinical significance in human ameloblastoma. NOM, OSCC, p-Akt
2015 NCAM (CD56) expression in keratin-producing odontogenic cysts: aberrant expression in KCOT. KCOTs, KPOCs, NBCS, NCAM, OOCs
10  2014 Transcriptional profiles of SHH pathway genes in keratocystic odontogenic tumor and ameloblastoma. KOT, NNM, SHH
11  2014 [Expression of survivin in ameloblastoma and its clinical significance]. ---
12  2012 Expression of phosphorylated mTOR and its regulatory protein is related to biological behaviors of ameloblastoma. ---
13  2011 Ameloblastic fibrosarcoma: a cytologist's perspective. AFS
14  2011 CD56 expression is associated with neuroectodermal differentiation in ameloblastomas: an immunohistochemical evaluation in comparison with odontogenic cystic lesions. DC, KCOT
15  2011 Reliance on diagnostic elements in panoramic imaging with focus on ameloblastoma and keratocystic odontogenic tumor: psychometric study. IeOC, KOT
16  2010 Evaluation of neoplastic nature of keratocystic odontogenic tumor versus ameloblastoma. caspase-3, KCOT, MMP-2, RC
17  2010 [Expression of p-p38MARK, uPA and Ki-67 in epithelial odontogenic tumour]. AOT, CCOT, CEOT, KCOT, p-p38 MAPK, uPA
18  2008 Evaluation of cell cycle-related indicators in plexiform ameloblastoma. PAB
19  2007 [DNA methylation of human telomerase reverse transcriptase promoter region in human ameloblastoma]. hTERT
20  2007 [Expression of HOX C13 in odontogenic tumors]. AF, CCOT, CEOT, KCOT
21  2007 [Expression of HOXC13 in ameloblastoma]. KCOT
22  2006 [Expression and significance of hTERT, c-fos and c-jun in ameloblastoma]. KCOT, NOM
23  2006 [Expression of nuclear factor-kappaB, Ki-67 and matrix metalloproteinase-9 in calcifying odontogenic cyst]. CCOT, COC, DGCT, GCOC, MMP-9, NF-kappaB
24  2005 [Expression of p21WAF1, p27KIP1 and cyclin E in ameloblastoma]. ---
25  2004 Parathyroid hormone-related protein (PTHrP) expression in ameloblastoma. PTHrP
26  2004 [Expression of pRb and E2F-1 and telomerase activity in ameloblastoma]. ---
27  2004 [Expression of telomerase activity and c-myc and stimulatory protein 1 in human ameloblastoma]. SP1
28  2004 [Research on the expression of c-myc mRNA in ameloblastoma]. NOM, OKC
29  2004 [The study of the invasive biologic behavior of ameloblastoma]. E-cad, MMP, VEGF
30  2003 [Expression of human telomerase reverse transcriptase and bcl-2 in ameloblastoma]. ---
31  2003 [Expression of ICAM-1 and VCAM-1 in human ameloblastoma and odontogenic keratocyst]. NOM, OKC
32  2003 [Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinase in ameloblastoma]. MMP, OKC, TIMP
33  2003 [Expression of telomerase activity and cyclin A in ameloblastoma]. OKC, PCNA
34  2003 [Expression of telomerase and p53 in ameloblastoma]. OKC
35  2002 Research on expression of telomerase in human odontogenic lesions. OKC
36  1995 p53 protein and Ki-67 reactivity in epithelial odontogenic lesions. An immunohistochemical study. DC, OC, OKC, p53P, RC